$CALM

Cal-Maine Foods (CALM) Q1 2027 Earnings Call Transcript

Cal-Maine Foods (CALM) reported Q1 2027 net sales of $539.6M, down 41.5% YoY, and a net loss of $58.6M. The decline was driven by lower conventional shell egg prices due to industry supply imbalances. Specialty shell egg and prepared foods sales also decreased. The company is investing in capacity expansion for prepared foods and remains debt-free with $767.6M in cash. Management expects future earnings growth from diversification and supply rebalancing.

Original reporting
Published Oct 1, 2026, 11:23 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 4:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cal-Maine Foods (CALM) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

The earnings miss may trigger short‑term sell‑off, but the company's cash reserves and expansion plans could support a longer‑term recovery.

02

Market read

First‑time disclosure of a sizable quarterly loss for Cal-Maine, a key player in the U.S. egg market.

03

What to watch

Strong cash position and debt‑free balance sheet provide flexibility for strategic moves.

Relevance 7/10Novelty 8/10Timing: after-hours earnings release

Background

Cal-Maine Foods reported its first quarter FY2027 results, highlighting a sharp revenue decline and ongoing capacity projects.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Q1 FY2027 earnings call disclosed a $58.6M net loss, 41.5% revenue drop and negative operating margin.

Expected impact

likely downward pressure as investors price in the loss and revenue decline

Evidence & confidence

The disclosed loss and margin contraction are new material facts; no mitigating guidance was provided.

Market effects

Egg and specialty food producers may see broader pressure from oversupplied conventional egg market.

U.S. egg producers face pricing headwinds; no immediate global effect.

Limited to agricultural commodities and related consumer staples sector.

Counterpoint

If capacity upgrades succeed, the stock could rebound despite short-term loss.

Key entities

  • Sherman Miller

    President and CEO of Cal-Maine Foods

  • Max Bowman

    Vice President and CFO of Cal-Maine Foods

Related articles

$CALMMed

Why Cal-Maine Foods Stock Dipped on Wednesday

Cal-Maine Foods reported Q1 2027 revenue of $539.6M, down 42% YoY, and a GAAP net loss of $58.6M ($1.26 per share). Both figures missed analyst estimates. The company suspended its dividend. Specialty eggs and prepared foods were profitable, but the core conventional egg business posted a loss of over $71M. The stock fell 0.7% on the news.

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$CALMMedAI 8/10

Maine Foods Q1 fiscal 2027 earnings loss

Cal-Maine Foods reported a Q1 2027 net loss of $58.6M, down from a $199.3M profit a year earlier, due to lower egg prices and sales. Net sales fell 41.5% to $539.6M. CEO Sherman Miller cited industry overproduction. Shares dropped 3.4% to $66.22. The company settled a price-rigging allegation earlier this year.

$CALMHighAI 8/10

Cal-Maine (CALM) Stock Trades Down, Here Is Why

Cal-Maine Foods (CALM) reported a Q3 2026 net loss, with net sales down 41.5% YoY to $539.6M, missing estimates. Gross profit fell to $403K, and the company posted a net loss of $58.6M. CEO Sherman Miller attributed results to industry supply imbalance. Shares fell 3%, trading at $66.49.